This article discusses patients with serorresis syphilis obtained as an additional - tion treatment by the following procedures: I - group (33.9%) were treated with penicillin for 1 Mill. U every 6 hours to a total dose - 120 million units;. Group II (26.3%) received treatment with ceftriaxone 1.0 intramuscularly 1 time per day for 16 days (amount - 16.0); Group III (39.8%) with ceftriaxone 1.0 daily for 16 days (16.0). In venereology, the problem of syphilitic seroresistance is of great importance. In addition, the study of the causal factors in the development of seroresis in syphilis is an important direction in science.
Vyazmina E.S., Novikov V.V., Dobrotina N.A., Novikova S.I., Frigo N.V., Komarova V.D. The content of soluble forms of antigens cd50 and hla class i in seroresistant forms of syphilis // Bulletin of the Nizhny Novgorod University named after I.I. N.I. Lobachevsky. Series: Biology. 2001. No. 1. S. 39-44.
Ryshkova N.S., Esipova E.A., Kharakhordina Yu.E. Socio-epidemiological profile of pregnant women with seroresistant syphilis // In the collection: University science: a look into the future. Materials of the international scientific-practical conference dedicated to the 81st anniversary of Kursk State Medical University and the 50th anniversary of the Faculty of Pharmacy. In 3 volumes. 2016.S. 185-188.
Popov V.E., Esipova E.A., Schwartz N.E., Kharakhordina Yu.E. Seroresistant syphilis in pregnant women // In the book: St. Petersburg Dermatological Readings. collection of abstracts of the X Jubilee scientific and practical conference of dermatovenerologists and cosmetologists. 2016.- S. 98.
Gafarov M.M., Nurislamov G.G., Mustafina G.R., Tukhvatullina Z.R. Modern features of the diagnosis and treatment of neurosyphilis // Bulletin of the Bashkir State Medical University. 2019.No. 1.P. 96-103.
Shilova AA, Pankratov OV The problem of seroresistance in syphilitic infection // Medical News. 2015. No. 3. S. 26-28.
Barycheva L.Yu., Minasyan M.M., Chebotarev V.V., Odinets A.V. Immunophenotyping of blood cells in patients with sero-resistant, early and late latent syphilis // Modern problems of science and education. 2017. No. 5.P. 130.